Bing-Shiou Yang

Title: The Innovations of Bing-Shiou Yang

Introduction

Bing-Shiou Yang is a notable inventor based in Dayton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of crystalline forms of various compounds. With a total of 2 patents, his work has implications for the treatment of serious health conditions.

Latest Patents

Yang's latest patents include innovative formulations aimed at addressing critical medical needs. One of his patents focuses on crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine and its salts and solvates. This invention outlines pharmaceutical compositions that utilize these crystalline forms for the treatment of HIV and/or AIDS, along with methods for obtaining them. Another patent involves crystalline forms of a factor Xa inhibitor, specifically 3-(1-hydroxy-1-methyl-ethyl)-1-(4-methoxy-phenyl)-6-[4-(2-oxo-2H-pyridin-1-yl)-phenyl]-1,4,5,6-tetrahydro-pyrazolo[3,4-c]pyridin-7-one and its solvates. This invention provides processes for producing these crystalline forms and methods for treating thromboembolic disorders.

Career Highlights

Bing-Shiou Yang is currently associated with Bristol-Myers Squibb Company, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug formulations that can significantly impact patient care.

Collaborations

Yang has collaborated with esteemed colleagues such as Chung-Pin H Chen and Dawn DiGiugno Parker. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Bing-Shiou Yang's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through scientific advancements. His patents reflect a deep understanding of complex medical challenges and a dedication to finding effective solutions.